Anaemia (cancer-treatment induced) - erythropoiesis-stimulating agents (epoetin and darbepoetin) (inc rev TA142) [ID541]: evaluation report
Table of Contents
- 01_NICE's response to comments on the Appraisal Consultation Document (ACD)
- 02_Consultee comments on the ACD - Amgen
- 03_Consultee comments on the ACD - Janssen
- 04_Consultee comments on the ACD - Sandoz
- 05_Public comments on the ACD received via the NICE website
Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report.
It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.
If you have any feedback on the new format please contact the Project Manager for this appraisal.
Anaemia (cancer-treatment induced) - erythropoiesis-stimulating agents (epoetin and darbepoetin) (inc rev TA142) [ID541]: evaluation report
24 October 2014 (420.47 Kb 2 sec) |
This page was last updated: 22 October 2014